Long-chain acyl-CoA synthetase 4 (ACSL4) is upregulated in HCC [180,181] and contributes to disease progression and poor prognosis by stabilizing c-Myc through the ERK/FBW7 axis [182]. The gene discussed is ACSL4; the disease is hepatocellular carcinoma.